Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1

Andrew L. Mammen, Arun Rajan, Katherine Pak, Tanya Lehky, Livia Casciola-Rosen, Renee N. Donahue, Lauren M. Lepone, Anastasia Zekeridou, Sean J. Pittock, Raffit Hassan, Jeffrey Schlom, James L. Gulley

Research output: Contribution to journalLetterpeer-review

29 Scopus citations
Original languageEnglish (US)
Pages (from-to)150-152
Number of pages3
JournalAnnals of the rheumatic diseases
Issue number1
StatePublished - Jan 1 2019


  • B cells
  • autoantibodies
  • autoimmune diseases
  • autoimmunity
  • polymyositis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • General Biochemistry, Genetics and Molecular Biology

Cite this